Yearly Archives: 2022

Position open for mass spectrometrist

  • November 24, 2022
  • Comments off

We are looking for an accomplished (Senior) Scientist with ample mass spectrometry expertise, to join the OncoProteomics Laboratory at the Amsterdam University Medical Center. Our focus is on innovative proteomics and data analysis strategies to improve (early) diagnostics and treatment of disease. As Proteomics Core Facility, the laboratory provides access to mass spectrometry for biomedical […]

Read More

Souvenir IMSC2022 Clinical Proteomics Course

  • September 20, 2022
  • Comments off

Picture Impression of the short course “Clinical Proteomics” at IMSC2022 in Maastricht. A great thanks to all the course contributors Sander Piersma, Irene Bijnsdorp and Tami Geiger.

Read More

Phosphoproteomics contribution published in Nature revealing that truncated FGFR2 leads to hyperactivity and is a clinically actionable oncogene

  • August 14, 2022
  • Comments off

Genetic alterations in the FGFR2 gene occur in various cancer types and represent a promising target for therapies. However, clinical responses to available therapies remained variable and unpredictable, making it difficult to select patients who would benefit from these types of treatments. An international team of researchers led by Jos Jonkers, group leader at the […]

Read More

CST Webinar Valentina

  • June 10, 2022
  • Comments off

Valentina presents her work in a presentation entitled “Uncovering novel targets for therapy in T-cell acute lymphoblastic leukemia using phosphoproteomics” at a Cell Signaling Webinar on Post Translational Modification next Tuesday June 14th at 15:00.

Read More

Plenary lecture Connie at EuPA2022 in Leipzig

  • June 1, 2022
  • Comments off

It was an honour and great pleasure to speak at the joint German Proteomics Forum -European Proteomics Association meeting in Leipzig on phosphoproteomics for precision medicine. See here for the program full of great science : https://www.proteomic-forum.com/programme/scientific-programme

Read More

Our review on high-dose vitamin C as multi-targeting anti-cancer agent: highly down-loaded in 2021

  • March 26, 2022
  • Comments off

The Journal of Experimental & Clinical Cancer Research (JECCR) has congratulated Connie Jimenez on authoring one of the most-downloaded papers published in the journal during 2021 (‘High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer’). Since publishing, the article has been downloaded 3144 times. Go see the article

Read More

Phosphoproteomics identifies new therapies for T-cell acute lymphoblastic leukemia

  • March 14, 2022
  • Comments off

Our study published Feb. 25 in Nature Communications shows that phosphoproteomic profiling can discover novel targets for therapy for T-ALL and it can guide the design of treatment combination strategies when a single therapy is not sufficient. The analysis of active proteins gives us a more complete picture of the leukemia and allows for selection […]

Read More